# HCW Biologics Inc.: Form 8-K, filed Jun 26, 2026

- Company: [HCW Biologics Inc.](/companies/hcwb.md) (CIK 1828673)
- Form: 8-K
- Filed: 2026-06-26
- Accepted by EDGAR: Jun 26, 2026, 13:00 ET
- Period: 2026-06-24
- Accession: 0001493152-26-030236
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1828673/000149315226030236/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1828673/000149315226030236/

## Items reported

- Item 3.03: Change to security holders’ rights
- Item 5.03: Amendment to articles or bylaws
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1828673/000149315226030236/form8-k.htm

Filed Jun 26, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-030236. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.